Literature DB >> 26522308

Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.

R Gniadecki1, B Bang2, C Sand2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26522308     DOI： 10.1111/bjd.14270

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

Review 1.  The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2018-08-09       Impact factor: 4.592

Review 2.  Selecting the Best Combined Biological Therapy for Refractory Inflammatory Bowel Disease Patients.

Authors:  Eduard Brunet Mas; Xavier Calvet Calvo
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

3.  Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis.

Authors:  Quinn Thibodeaux; Karen Ly; Vidhatha Reddy; Mary Patricia Smith; Wilson Liao
Journal:  JAAD Case Rep       Date:  2019-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.